To reach the lungs, medicine from an inhaler must navigate the narrow passage of the throat, as seen in his aluminum model, without sticking to the moist sides of the passage. Tens of millions of ...

GRAND RAPIDS, Mich. (WOOD) — Many people manage their asthma with an inhaler — but they may not be using it correctly. Studies show that nearly 90% of patients with an inhaler make at least one ...

Nearly six-and-a-half million children in the United States suffer from asthma. Most use an inhaler to help keep their airways open. But experts say most children make mistakes when using an inhaler.

NEW YORK (CBSNewYork) -- Six and a half million children in the United States suffer from asthma and use inhalers to keep their airways open, but most kids aren't using them correctly, dramatically ...

An icon in the shape of a lightning bolt. Impact Link Inhalers may be prescribed to people who have a variety of health conditions both chronic and acute, including asthma, chronic obstructive ...

A new study suggests that many patients aren’t waiting between puffs on their inhalers and may not be deriving the full benefits of the drugs. By Perri Klass, M.D. Asthma is the most common chronic ...

CHICAGO, March 18 (UPI) --A new method of teaching asthma and COPD patients to properly use inhalers can prevent adverse health events, according to a recent study. Researchers at the University of ...

(Reuters Health) – Less than one in five people who need to use asthma inhalers or epinephrine auto-injectors know how to use them properly, a small U.S. study suggests People with severe allergies or ...

In the first study to evaluate inhaler technique in children hospitalized for asthma - the group at highest risk for complications and death from asthma - researchers found that nearly half of ...

New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD exacerbation with a dry powder inhaler vs. a metered-dose or soft mist ...

Researchers with two pharmaceutical companies are nearing the final stages of developing an inhaler they said offers an antibody-based treatment to COVID-19. Augmenta Bioworks and TFF Pharmaceuticals' ...